| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―12 |
Coronavirus spike protein-based vaccines. Vaccine delivery systems |
Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu, Mingjie Shi, Huiyuan Wang, Sharafitdin Mirzaakhmedov, et al. (+3) Amit Kumar Nayak, Ibrokhim Y. Abdurakhmonov, Yongzhuo Huang |
| 2 |
[GO] |
2022―Nov―29 |
Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning |
Maanaskumar R. Gantla, Igor F. Tsigelny, Valentina L. Kouznetsova |
| 3 |
[GO] |
2022―Nov―09 |
Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr Virus and SARS-CoV-2, an in silico study |
Omkar Indari, Ajit Kumar Singh, Deeksha Tiwari, Hem Chandra Jha, Anupam Nath Jha |
| 4 |
[GO] |
2022―Jun―13 |
Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19 |
Sowbarnika Ravichandran, Nivethitha Manickam, Mahesh Kandasamy |
| 5 |
[GO] |
2021―Dec―04 |
The Delta Variant Mutations in the Receptor Binding Domain of SARS-CoV-2 Show Enhanced Electrostatic Interactions with the ACE2 |
Shaimaa S. Goher, Fedaa Ali, Muhamed Amin |
| 6 |
[GO] |
2021―Aug―06 |
Liposomes and mRNA: two technologies together create a COVID-19 vaccine |
Gregory Gregoriadis |
| 7 |
[GO] |
2021―May―25 |
Antiviral performance of graphene-based materials with emphasis on COVID-19: A review |
Tahereh Seifi, Ali Reza Kamali |
| 8 |
[GO] |
2021―Mar―30 |
Network bioinformatics analysis provides insight into drug repurposing for COVID-19 |
Xu Li, Jinchao Yu, Zhiming Zhang, Jing Ren, Alex E Peluffo, Wen Zhang, et al. (+5) Yujie Zhao, Jiawei Wu, Kaijing Yan, Daniel Cohen, Wenjia Wang |
| 9 |
[GO] |
2021―Mar―19 |
New threatening of SARS-CoV-2 co-infection and strategies to fight the current pandemic |
Nikky Goel, Razi Ahmad, Huma Fatima, Sunil Kumar Khare |
| 10 |
[GO] |
2021―Mar―11 |
The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review |
Subham Das, K.R. Anu, Sumit Birangal, Saleem Akbar, Bahar Ahmed, Alex Joseph |
| 11 |
[GO] |
2021―Mar―02 |
The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant |
Fedaa Ali, Amal Kasry, Muhamed Amin |
| 12 |
[GO] |
2020―Dec―24 |
AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate |
Marcin Delijewski, Jacek Haneczok |
| 13 |
[GO] |
2020―Oct―20 |
Protein-driven mechanism of multiorgan damage in COVID-19 |
Ernesto Estrada |
| 14 |
[GO] |
2020―Sep―18 |
Serum levels of Vitamin C and Vitamin D in a cohort of critically ill COVID-19 patients of a North American Community Hospital Intensive Care Unit in May 2020. A Pilot Study |
Cristian Arvinte, Maharaj Singh, Paul E. Marik |
| 15 |
[GO] |
2020―Jul―24 |
Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19) |
Di Liu, Qiang Wang, Huacai Zhang, Li Cui, Feng Shen, Yong Chen, et al. (+9) Jiali Sun, Lebin Gan, Jianhui Sun, Jun Wang, Jing Zhang, Qingli Cai, Jin Deng, Jianxin Jiang, Ling Zeng |
| 16 |
[GO] |
2020―Jul―16 |
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19 |
Chenglong Liu, Di Zhu |
| 17 |
[GO] |
2020―Jun―19 |
ET-traps as a potential treatment for COVID-19 |
Arjun Jain, Vidhi Mehrotra |
| 18 |
[GO] |
2020―Jun―05 |
Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19 |
B. Solun, Y. Shoenfeld |
| 19 |
[GO] |
2020―Jun―02 |
Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control? |
Mingyan Deng, Ling Jiang, Yan Ren, Jiayu Liao |
| 20 |
[GO] |
2020―Jun―02 |
Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation? |
Karan Razdan, Kuldeep Singh, Dilpreet Singh |
| 21 |
[GO] |
2020―May―27 |
BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope? |
Keshav Rajarshi, Aroni Chatterjee, Shashikant Ray |
| 22 |
[GO] |
2020―May―15 |
COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF) |
Su M. Metcalfe |
| 23 |
[GO] |
2020―May―11 |
Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis |
Russel J. Reiter, Ramaswamy Sharma, Qiang Ma, Alberto Dominquez-Rodriguez, Paul E. Marik, Pedro Abreu-Gonzalez |
| 24 |
[GO] |
2020―Apr―29 |
Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19 |
Mahesh Kandasamy |
| 25 |
[GO] |
2020―Apr―29 |
Does vitamin D status impact mortality from SARS-CoV-2 infection? |
Paul E. Marik, Pierre Kory, Joseph Varon |
| 26 |
[GO] |
2020―Apr―19 |
PAK1-blockers: Potential Therapeutics against COVID-19 |
Hiroshi Maruta, Hong He |
| 27 |
[GO] |
2020―Apr―13 |
Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies |
Jiayu Liao, George Way, Vipul Madahar |
| 28 |
[GO] |
2020―Apr―09 |
Meeting the Potential Emergency Global Drug Supply Challenge of Hydroxychloroquine for COVID-19 |
Tony Y. Zhang, Boyu Zhong |
| 29 |
[GO] |
2020―Apr―04 |
The role of afferent pulmonary innervation in poor prognosis of acute respiratory distress syndrome in COVID-19 patients and proposed use of resiniferatoxin (RTX) to improve patient outcomes in advanced disease state: A review |
Alexis Nahama, Roshni Ramachandran, Alvaro Francisco Cisternas, Henry Ji |
| 30 |
[GO] |
2020―Apr―03 |
Standing out from the crowd in treating COVID-19 |
Kim D. Janda, Michael J. Iadarola |
| 31 |
[GO] |
2020―Mar―26 |
Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? |
Richard Z. Cheng |
| 32 |
[GO] |
2020―Mar―25 |
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus |
Henry Ji, Ying Yan, Beibei Ding, Wenzhong Guo, Mark Brunswick, Andreas Niethammer, et al. (+4) Williams SooHoo, Robin Smith, Alexis Nahama, Yanliang Zhang |
| 33 |
[GO] |
2020―Mar―19 |
Mesenchymal stem cells and management of COVID-19 pneumonia |
Su M. Metcalfe |
